CD158k Is a Reliable Marker for Diagnosis of Sézary Syndrome and Reveals an Unprecedented Heterogeneity of Circulating Malignant Cells

2014/08/26 by Hélène Moins‐Teisserenc, Hélène Moins-Teisserenc, Magali Daubord +15 · 17 citations
Medicine · #Cutaneous lymphoproliferative disorders research #CAR-T cell therapy research #Lymphoma Diagnosis and Treatment

paper · pdf · doi:10.1038/jid.2014.356

Cited by

• CD164 identifies CD4 + T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214. [europepmc]
• Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas. [europepmc]
• Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification. [europepmc]
• Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sézary Syndrome. [europepmc]
• ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells. [europepmc]
• Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity. [europepmc]
• Novel targeted therapies of T cell lymphomas. [europepmc]
• CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome. [europepmc]
• CCR4 as a Therapeutic Target for Cancer Immunotherapy. [europepmc]
• Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardized approach. [europepmc]
• Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma. [europepmc]
• CCR8 is a new therapeutic target in cutaneous T-cell lymphomas. [europepmc]
• Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma. [europepmc]
• Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome. [europepmc]
• Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon. [europepmc]
• Delving into the Metabolism of Sézary Cells: A Brief Review. [europepmc]
• Revisiting the Origins of Cutaneous T-Cell Lymphoma: A Progenitor-Based Model. [europepmc]